#biotechnology

Coffee wilt disease has cost over $1 billion and reshaped global coffee supply. How a fungal pathogen is evolving to threaten our daily caffeine fix.

This year's severe flu season reveals why we need universal vaccines. With 650,000 annual deaths globally, could we finally eliminate influenza for good?

As high-grade ore depletes, biotech startups are engineering microbes to extract metals from aging mines and waste. But can biology scale fast enough for the EV boom?

With a 75% fatality rate and no effective treatment, Nipah virus poses a growing threat. A Japanese vaccine candidate begins clinical trials in Belgium this April as new cases emerge in India.

China is achieving significant milestones in its 'China agricultural seed self-reliance 2026' initiative, replacing foreign genetics with domestic varieties.

A China-led team has developed the world's first mini-womb on a chip, replicating human embryo implantation to solve infertility mysteries and improve IVF success.

Explore the modern vaccine manufacturing science, from live attenuated viruses to the truth about ingredients like adjuvants and thimerosal.

Five years after its debut, Google DeepMind's AlphaFold is evolving from a protein structure predictor into an 'AI co-scientist.' Built on Gemini 2.0, it's generating hypotheses and tackling the grand challenge of simulating a human cell.

A top US-trained scientist's return to China is not an isolated event. It's a critical signal of a reversing brain drain in the global tech and talent war.

A massive blood-smuggling bust in China is more than a crime story. It's a signal of Beijing's new biosecurity state and a new front in the US-China tech war.

The new US NDAA isn't just a defense bill; it's a strategic move to decouple key tech and biotech sectors from China. We analyze the global impact.